Bhagiradha Chemicals & Industries Ltd
BHAGCHEMBhagiradha Chemicals & Industries Ltd's earnings have outrun its stock. EPS grew +30.8% in a year against a −10.5% price move.
The sharpest disagreement: profits are rising, but only −14% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch.
The price is in a confirmed uptrend (6 weeks in) while the P/E sits at the 79th percentile of its own 6-year range. Underneath, the last four quarters read improving, and −14% of the last 3 years' profit arrived as cash. What settles it: whether the cash starts following the profit.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Bhagiradha Chemicals & Industries Ltd trades at ₹270, in a confirmed uptrend and 6 weeks into that stage. That is +8.1% against its own 200-day average. It sits at 78% of a 52-week range of ₹180 to ₹296. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 18 straight weeks.
Today the stock is in a confirmed uptrend — week 6 of stage 2, confirmed. At ₹270 it trades +8.1% versus its 200-day average and sits at 78% of its 52-week range (₹180–₹296).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +3,394% while the NIFTY 500 moved +280% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 18 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/E sits at the 79th percentile of its own range.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Bhagiradha Chemicals & Industries Ltd trades at 188.0× P/E, at the pricey end of its own range (79th percentile). Its long-run median P/E is 74.3×, measured across 5.7 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 188.0× is at the pricey end of its own range (79th percentile), against a long-run median of 74.3× measured over 5.7 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +30.8% against a −10.5% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +34.0%/yr price move, ~−8.7%/yr came from earnings growth and ~+42.7 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: Improving Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Bhagiradha Chemicals & Industries Ltd reads as improving on its fundamental arc. Improving — profit growth bottomed 8 quarters ago at −56.3% and has held its recovery at +31.1%, ROCE holding at 4.8%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: a sustained climb off the trough is the setup this page is built to catch — the question moves to what you pay for it.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +21.8% | +2.2% | +11.0% | — |
| Profit | +28.6% | −26.3% | −4.8% | — |
| EPS | +30.8% | −31.4% | −9.2% | — |
| Share price | −10.5% | +24.4% | +34.0% | +38.1% |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
52.5/100 — rank 10 of 24 in Pesticides/Agrochemicals · 88% evidence confidence
Bhagiradha Chemicals & Industries Ltd scores 52.5 out of 100 against the 24 companies it is compared with in Pesticides/Agrochemicals, ranking 10. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 23.6 + 7.9 + 1.7 + 19.3 = 52.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Bhagiradha Chemicals & Industries Ltd reported ₹158 Cr of revenue in the Mar 26 quarter, +28.9% year on year. That is the 6th straight quarter of year-on-year growth. Over 6 years it has compounded at 13.9% a year. The last full year, FY26, came in at ₹536 Cr. The last four reported quarters add to ₹536 Cr.
Bhagiradha Chemicals & Industries Ltd reported ₹158 Cr of revenue in the Mar 26 quarter, +28.9% year on year. That is the 6th straight quarter of year-on-year growth. Over 6 years it has compounded at 13.9% a year. The last full year, FY26, came in at ₹536 Cr. The last four reported quarters add to ₹536 Cr.
FY26 revenue came in at ₹536 Cr (+21.8% on the year), capping 6 years at 13.9% compound. The latest quarter (Mar 26) printed ₹158 Cr, +28.9% year on year — the 6th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +21.5% growth against the decade's 13.9% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +21.7% over the last 4 quarters against +14.7%/yr over the last 8 — accelerating; TTM profit +31.1% vs −0.2%/yr — accelerating.
→ Revenue grew — did margins hold as it scaled? Next: 12.3% this quarter (+7.3 pp YoY).
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Bhagiradha Chemicals & Industries Ltd's operating margin is 12.3% in the Mar 26 quarter, +7.3 percentage points against the same quarter a year ago. Across 7 fiscal years the operating margin has ranged 7.0% to 16.0%. The current quarter sits inside that band.
Bhagiradha Chemicals & Industries Ltd's operating margin is 12.3% in the Mar 26 quarter, +7.3 percentage points against the same quarter a year ago. Across 7 fiscal years the operating margin has ranged 7.0% to 16.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 12.3%, +7.3 pp against the same quarter a year ago. Across 7 fiscal years the operating margin has ranged 7.0%–16.0%.
Why the margin moved: operating margin went +7.3 pp year on year while gross margin went +7.2 pp — the gain came mostly from the gross line: input costs and pricing.
→ Margins held — did that reach the bottom line? Next: profit null in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Bhagiradha Chemicals & Industries Ltd earned ₹4.1 Cr of net profit in the Mar 26 quarter. Full-year FY26 profit was ₹18.0 Cr. The 6-year compound rate is 17.0%. That is 2.6% of the quarter's revenue. The same quarter a year earlier lost ₹0.9 Cr. 1 of the last 12 reported quarters were loss-making.
Bhagiradha Chemicals & Industries Ltd earned ₹4.1 Cr of net profit in the Mar 26 quarter. Full-year FY26 profit was ₹18.0 Cr. The 6-year compound rate is 17.0%. That is 2.6% of the quarter's revenue. The same quarter a year earlier lost ₹0.9 Cr. 1 of the last 12 reported quarters were loss-making.
Mar 26 profit was ₹4.1 Cr, null year on year. On the full year, FY26 printed ₹18.0 Cr (+28.6%), and the 6-year compound rate is 17.0%.
Pace comparison, last four quarters: profit −0.2% vs revenue +21.5%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
→ Profit rose — but did the cash follow? Next: −14% of the last 3 years' profit arrived as cash.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years −14% of Bhagiradha Chemicals & Industries Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹12.0 Cr of operating cash against ₹18.0 Cr of profit. After ₹163 Cr of capital spending, ₹−151 Cr was left as free cash.
FY26: operating cash of ₹12.0 Cr against reported profit of ₹18.0 Cr, leaving free cash of ₹−151 Cr after ₹163 Cr of capital spending. Across the last 3 fiscal years the conversion rate is −14% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at −14%: the cash cycle stretched 72 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: conversion is below par and the cash cycle has stretched 72 days — the next section's job is to find where the cash is stuck.
→ So follow the cash to where it goes. Next: the 148-day cycle, in money terms.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Bhagiradha Chemicals & Industries Ltd's cash conversion cycle runs 148 days in FY26, up from 76 days in FY21. Capital spending ran ₹521 Cr over the last 3 years. At FY26 sales of ₹536 Cr each day of that cycle holds about ₹1.5 Cr, so roughly ₹217 Cr sits inside the business at any moment.
FY26: debtors at 139 days, inventory at 161 days — roughly 5.3 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 148 days, looser than FY21's 76.
The full loop: cash goes out to suppliers and production on day 0; stock waits 161 days to sell; customers pay about 139 days after that; and suppliers themselves are paid at 152 days — netting out to the 148-day cycle.
In money terms: at FY26 sales of ₹536 Cr, each day of the cycle holds about ₹1.5 Cr — so the 148-day loop keeps roughly ₹217 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹521 Cr over the last 3 fiscal years against ₹46.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹96.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
→ Does all this activity actually earn its cost of capital? Next: ROCE is 5% and the ROIC − WACC spread is −8.5 pp.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Bhagiradha Chemicals & Industries Ltd earns a ROCE of 5% in FY26. That is up from a trough of 5% in FY25. Return on invested capital clears the cost of that capital by −8.5 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 3.4% net margin on 0.48× asset turns.
FY26 ROCE is 5%, recovered from a FY25 trough of 5% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 3.4% net margin × 0.48× asset turns × 1.60× balance-sheet leverage ≈ 2.6% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 3.5% − 12.0% = a −8.5 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.34.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Bhagiradha Chemicals & Industries Ltd carries total debt of ₹234 Cr against shareholder equity of ₹698 Cr as of Mar 26, a debt-to-equity of 0.34. On the annual view that ratio went from 0.43 in FY22 to 0.34 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹234 Cr against shareholder equity of ₹698 Cr — a debt-to-equity of 0.34. On the annual view, debt-to-equity went from 0.43 (FY22) to 0.34 (FY26). Read the returns on this page with that leverage in mind.
→ Who owns this, and are they adding or leaving? Next: the register is quiet.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Bhagiradha Chemicals & Industries Ltd moved a full percentage point over the last two years — the register is quiet. Foreign institutions moved −0.1 points over the same window, to 0.1%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −0.7 points over 8 quarters to 19.6%; Foreign institutions: −0.1 points over 8 quarters to 0.1%; Domestic institutions: −0.1 points over 8 quarters to 3.0%. Note the structure: promoters hold under 20% — this is a widely-held company where institutions, not a family, set the direction.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Bhagiradha Chemicals & Industries Ltd: the Z-score reads 5.80. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 5.80 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 5.80.
| Company | P/E | Mkt cap | Revenue | EPS | ROCE | Stage |
|---|---|---|---|---|---|---|
| Bhagiradha Chemicals & Industries Ltd this page | 188.0× | ₹3,416 Cr | Improving | |||
| UPL Ltd | 28.2× | ₹50,841 Cr | No read | |||
| P I Industries Ltd | 34.5× | ₹41,437 Cr | Deteriorating | |||
| Sumitomo Chemical India Ltd | 50.9× | ₹25,978 Cr | Mixed | |||
| Bayer CropScience Ltd | 385.0× | ₹18,954 Cr | — | — | — | — |
| Jubilant Ingrevia Ltd | 36.3× | ₹11,557 Cr | Mixed | |||
| Sharda Cropchem Ltd | 12.1× | ₹7,876 Cr | Mixed | |||
| Epigral Ltd | 15.2× | ₹5,016 Cr | Mixed | |||
| NACL Industries Ltd | 178.0× | ₹4,610 Cr | No read | |||
| Dhanuka Agritech Ltd | 15.5× | ₹4,517 Cr | Topping out | |||
| Rallis India Ltd | 26.9× | ₹4,253 Cr | Mixed | |||
| GSP Crop Science Ltd | 24.4× | ₹2,468 Cr | — | — | — | — |
| Bharat Rasayan Ltd | 13.1× | ₹2,096 Cr | Mixed | |||
| Insecticides India Ltd | 12.9× | ₹1,793 Cr | Mixed | |||
| India Pesticides Ltd | 14.4× | ₹1,727 Cr | Mixed | |||
| Titan Biotech Ltd | 57.5× | ₹1,719 Cr | Turning around | |||
| Astec Lifesciences Ltd | — | ₹1,469 Cr | No read | |||
| Meghmani Organics Ltd | 48.2× | ₹1,385 Cr | No read | |||
| Punjab Chemicals & Crop Protection Ltd | 21.0× | ₹1,375 Cr | Mixed | |||
| Excel Industries Ltd | 15.5× | ₹1,172 Cr | Mixed | |||
| Titan Biotech Ltd | 42.0× | ₹1,141 Cr | Turning around | |||
| Dharmaj Crop Guard Ltd | 16.1× | ₹882 Cr | No read | |||
| Advance Agrolife Ltd | 20.0× | ₹706 Cr | No read | |||
| Heranba Industries Ltd | — | ₹700 Cr | No read | |||
| Best Agrolife Ltd | 60.6× | ₹538 Cr | No read |
Frequently asked questions
What is Bhagiradha Chemicals & Industries Ltd's share price today?
Bhagiradha Chemicals & Industries Ltd trades at ₹270, −10.5% over the past year. The company is valued at ₹3,416 Cr. The stock sits at 78% of its 52-week range of ₹180–₹296, +8.1% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 6 weeks in. — as of 24 July 2026.
What were Bhagiradha Chemicals & Industries Ltd's latest quarterly results?
Bhagiradha Chemicals & Industries Ltd reported revenue of ₹158 Cr and net profit of ₹4.1 Cr for the Mar 26 quarter. Earnings per share were ₹0.31. The operating margin was 12.3%, 7.3 pp higher than a year earlier. — as of 24 July 2026.
What is Bhagiradha Chemicals & Industries Ltd's revenue?
Bhagiradha Chemicals & Industries Ltd reported revenue of ₹158 Cr in the Mar 26 quarter, +28.9% year on year. For the full FY26 fiscal year, revenue was ₹536 Cr (+21.8%). Over the last 6 years revenue compounded at 13.9% a year. — as of 24 July 2026.
What is Bhagiradha Chemicals & Industries Ltd's profit?
Bhagiradha Chemicals & Industries Ltd earned ₹4.1 Cr of net profit in the Mar 26 quarter. Full-year FY26 profit was ₹18.0 Cr. The operating margin ran 12.3% in the latest quarter. — as of 24 July 2026.
What is Bhagiradha Chemicals & Industries Ltd's market cap?
Bhagiradha Chemicals & Industries Ltd's market capitalisation is ₹3,416 Cr at a share price of ₹270. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 24 July 2026.
What is Bhagiradha Chemicals & Industries Ltd's P/E ratio?
Bhagiradha Chemicals & Industries Ltd trades at a P/E of 188.0×, at the 79th percentile of its own 6-year range, against a long-run median of 74.3×. This is a comparison with the stock's own history, not a value call — as of 24 July 2026.
Does Bhagiradha Chemicals & Industries Ltd pay a dividend?
Yes — Bhagiradha Chemicals & Industries Ltd's dividend payout was 11% of profit in FY26, and it recorded a payout in 5 of its last 7 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 24 July 2026.
Is Bhagiradha Chemicals & Industries Ltd overvalued?
On its own history, Bhagiradha Chemicals & Industries Ltd looks expensive against its own history: its P/E of 188.0× sits at the 79th percentile of its 6-year range (long-run median 74.3×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 24 July 2026.
How is Bhagiradha Chemicals & Industries Ltd performing?
Bhagiradha Chemicals & Industries Ltd is in a confirmed uptrend, 6 weeks in. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 18 weeks. This describes what the data did, not a rating. — as of 24 July 2026.
What stage is Bhagiradha Chemicals & Industries Ltd in?
Improving — profit growth bottomed 8 quarters ago at −56.3% and has held its recovery at +31.1%, ROCE holding at 4.8%. The read comes from the last 12 quarters of growth (revenue growth +21.7% latest, profit growth +31.1% latest, eps growth +25.0% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 24 July 2026.
Is Bhagiradha Chemicals & Industries Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 6 of stage 2), trading +8.1% versus its 200-day average and at 78% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 24 July 2026.
Is Bhagiradha Chemicals & Industries Ltd beating the market?
On recent form, yes — Bhagiradha Chemicals & Industries Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 18 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +3,394% against the NIFTY 500's +280% — ahead of the index over the full window. — as of 24 July 2026.
Will Bhagiradha Chemicals & Industries Ltd's share price go up?
This page publishes no price forecast for Bhagiradha Chemicals & Industries Ltd. What it measures instead: the share price is ₹270, the price is in a confirmed uptrend 6 weeks in. Its P/E of 188.0× sits at the 79th percentile of its own 6-year range. — as of 24 July 2026.
Who owns Bhagiradha Chemicals & Industries Ltd?
Promoters hold 19.6% of Bhagiradha Chemicals & Industries Ltd, foreign institutions 0.1%, domestic institutions 3.0% and the public 77.3% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 24 July 2026.
Does Bhagiradha Chemicals & Industries Ltd have too much debt?
It is moderate — Bhagiradha Chemicals & Industries Ltd's debt-to-equity is 0.34, and operating profit covers the interest bill 3×. FY26 borrowings were ₹235 Cr against equity of ₹698 Cr. Read the returns on this page with that leverage in mind — as of 24 July 2026.
What is Bhagiradha Chemicals & Industries Ltd's capex?
Bhagiradha Chemicals & Industries Ltd spent ₹521 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹163 Cr, with ₹96.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 24 July 2026.
What is Bhagiradha Chemicals & Industries Ltd's cash flow?
Bhagiradha Chemicals & Industries Ltd generated ₹12.0 Cr of operating cash flow in FY26 and ₹−151 Cr of free cash flow after ₹163 Cr of capital spending. Reported profit that year was ₹18.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 24 July 2026.
Is Bhagiradha Chemicals & Industries Ltd's profit real cash?
Not fully — over the last 3 fiscal years, −14% of Bhagiradha Chemicals & Industries Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹12.0 Cr against reported profit of ₹18.0 Cr. The cash then goes mostly into the working-capital cycle. Cash-flow resolution is annual — as of 24 July 2026.
How financially safe is Bhagiradha Chemicals & Industries Ltd?
On the balance sheet, the Z-score reads 5.80 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 24 July 2026.
Where is Bhagiradha Chemicals & Industries Ltd in its business cycle?
Bhagiradha Chemicals & Industries Ltd's FY26 operating margin was 11.0%, against a 7-year band of 7.0%–16.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 12.3%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 24 July 2026.
What could break the Bhagiradha Chemicals & Industries Ltd story?
The sharpest disagreement: profits are rising, but only −14% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 24 July 2026.
Is Bhagiradha Chemicals & Industries Ltd a stock worth studying right now?
This is not investment advice. The machine read: Bhagiradha Chemicals & Industries Ltd's earnings have outrun its stock. EPS grew +30.8% in a year against a −10.5% price move. The sharpest open question: whether the cash starts following the profit. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 24 July 2026.